Accurate de novo design of high-affinity protein-binding macrocycles using deep learning
Top Cited Papers
Open Access
- 20 June 2025
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 21 (12) , 1948-1956
Abstract
Developing macrocyclic binders to therapeutic proteins typically relies on large-scale screening methods that are resource intensive and provide little control over binding mode. Despite progress in protein design, there are currently no robust approaches for de novo design of protein-binding macrocycles. Here we introduce RFpeptides, a denoising diffusion-based pipeline for designing macrocyclic binders against protein targets of interest. We tested 20 or fewer designed macrocycles against each of four diverse proteins and obtained binders with medium to high affinity against all targets. For one of the targets, Rhombotarget A (RbtA), we designed a high-affinity binder ( K d < 10 nM) despite starting from the predicted target structure. X-ray structures for macrocycle-bound myeloid cell leukemia 1, γ-aminobutyric acid type A receptor-associated protein and RbtA complexes match closely with the computational models, with a Cα root-mean-square deviation < 1.5 Å to the design models. RFpeptides provides a framework for rapid and custom design of macrocyclic peptides for diagnostic and therapeutic applications.Keywords
This publication has 57 references indexed in Scilit:
- Exploring Arylidene–Indolinone Ligands of Autophagy Proteins LC3B and GABARAPACS Medicinal Chemistry Letters, 2025
- HelixDiff, a Score-Based Diffusion Model for Generating All-Atom α-Helical StructuresACS Central Science, 2024
- Accurate de novo design of membrane-traversing macrocyclesCell, 2022
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- Autophagic bulk sequestration of cytosolic cargo is independent of LC3, but requires GABARAPsExperimental Cell Research, 2015
- Peptide therapeutics: Targeting the undruggable spaceEuropean Journal of Medicinal Chemistry, 2015
- Mcl‐1–Bim complexes accommodate surprising point mutations via minor structural changesProtein Science, 2010
- Ligand Binding Mode of GABAA Receptor-Associated ProteinJournal of Molecular Biology, 2008
- New fusion protein systems designed to give soluble expression inEscherichia coliBiotechnology and Bioengineering, 1999